Differential effect of vascularity between long- and short-term survivors with IDH1/2 wild-type glioblastoma.
María Del Mar Álvarez-TorresElies Fuster-GarciaGaspar ReynésJavier Juan-AlbarracínEduard ChelebianLaura OleagaJose PinedaCristina AugerAlex RoviraKyrre E EmblemSilvano FiliceEnrique Mollà-OlmosJuan Miguel García-GómezPublished in: NMR in biomedicine (2021)
We have found different prognostic and stratification effects of the vascular marker for the LTS and STS groups. We propose the use of rCBVmean at HAT as a vascular marker clinically relevant for LTSs with IDH1/2 wt GB and maybe as a potential target for randomized clinical trials focused on this group of patients.